Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer
{{output}}
Triple-negative breast cancer accounts for approximately 15% of all diagnosed breast cancers and is characterized by an aggressive clinical course resulting from rapid proliferation of tumor cells poses a huge therapeutic challenge. The shortened, in compariso... ...